BCL2 and acute lymphoblastic leukemia: A recent follow-up study by this group identified upregulation of the IL7R in Zeb2 transgenic ETP-ALL cells as driving IL7-mediated activation of JAK/STAT signaling and upregulation of the pro-survival protein BCL2.